Phibro Animal Health (PAHC) Other Non Operating Income (2012 - 2026)
Phibro Animal Health (PAHC) posted quarterly Other Non Operating Income of -$1.9 million for Q1 2026, down 134.53% year-over-year from $5.5 million in Q1 2025, and up 11.0% quarter-over-quarter from -$2.1 million in Q4 2025.
Phibro Animal Health (PAHC) Other Non Operating Income (2012 - 2026) Analysis & Trends
Phibro Animal Health's Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 134.53% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$8.2 million (up 40.56% YoY), while the FY2025 annual figure was -$7.9 million, up 67.02% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$1.9 million, up from -$2.1 million in the prior quarter.
- The five-year high for Other Non Operating Income was $10.6 million in Q1 2022, with the low at -$11.7 million in Q4 2024.
- The 5-year median for Other Non Operating Income is -$2.1 million (2025), against an average of -$2.2 million.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income jumped 1712.01% in 2022, then slumped 5118.12% in 2023.
- Phibro Animal Health's Other Non Operating Income stood at $149000.0 in 2022, then plunged by 5118.12% to -$7.5 million in 2023, then tumbled by 56.47% to -$11.7 million in 2024, then jumped by 81.67% to -$2.1 million in 2025, then grew by 11.0% to -$1.9 million in 2026.
- Business Quant data shows PAHC's Other Non Operating Income at -$1.9 million in Q1 2026, -$2.1 million in Q4 2025, and -$2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.36 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.91 Mn |
| Dec 31, 2025 | -2.15 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Jun 30, 2025 | -1.26 Mn |
| Mar 31, 2025 | 5.53 Mn |
| Dec 31, 2024 | -11.70 Mn |
| Sep 30, 2024 | -438,000.00 |
| Jun 30, 2024 | -7.27 Mn |
| Mar 31, 2024 | -2.43 Mn |
| Dec 31, 2023 | -7.48 Mn |
| Sep 30, 2023 | -6.69 Mn |
| Jun 30, 2023 | 2.17 Mn |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 149,000.00 |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -7.41 Mn |
| Mar 31, 2022 | 10.56 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | -2.13 Mn |
| Jun 30, 2021 | 890,000.00 |